Metabo-Oncology
About Metabo-Oncology
Mission
Contributors
Publications
Contact
Expert Perspectives
Medical Treatment Perspectives
Exercise, Diet, Nutrition
Epidemiology — The Evidence Is Clear
Research: How Obesity Makes Cancer More Lethal
For Doctors
For Researchers
News & Events
Publications
Obesity, Metabolic Dysfunction and Their Negative Impacts on Cancer Treatments
Perry et al., 2020, Mechanistic Links
between Obesity, Insulin, and Cancer
Arrieta et al., 2019, Combination of metformin plus TKI vs. TKI alone in EGFR(+) LUNG adenocarcinoma: A randomized phase II study
Hopkins et al., 2018, Suppression of insulin feedback enhances the efficacy of PI3K inhibitors
Michelet et al., 2018, Metabolic reprogramming of natural killer cells in obesity limits antitumor responses
Murphy et al., 2018, Elevated Leptin during Diet-Induced Obesity Reduces the Efficacy of Tumor Immunotherapy
Aguilar et al., 2018,
Obesity induced T cell dysfunction and implications for cancer immunotherapy
Incio et al., 2018, Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2
Wei et al., 2015 The impact of insulin on chemotherapeutic sensitivity to 5-fluorouracil in gastric cancer cell lines SGC7901, MKN45 and MKN28
Obesity and Cancer: Mechanisms Underlying Progression and Metastases
Schmidt et al., 2018, Cancer Cachexia: More Than Skeletal Muscle Wasting
Quail et al., 2018, The obese adipose tissue microenvironment in cancer development and progression
Iyengar et al., 2017, Metabolic Obesity, Adipose Inflammation and Elevated Breast Aromatase in Women with Normal Body Mass Index
Quail et al., 2017, Obesity alters the lung myeloid cell landscape to enhance breast cancer metastasis through IL5 and GM-CSF
Goodwin et al., 2002, Fasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Duan at al., 2013, Obesity, adipokines and hepatocellular carcinoma
Morris et al., 2011, Inflammation and Increased Aromatase Expression Occur in the Breast Tissue of Obese Women with Breast Cancer
Frisch et al., 2015, Non-small cell lung cancer cell survival crucially depends on functional insulin receptors
Lengyel et al., 2018, Cancer as a Matter of Fat: The Crosstalk between Adipose Tissue and Tumors
Iyengar et al., 2016, Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation
Chettouh et al., 2015, Hyperinsulinaemia and insulin signaling in the pathogenesis and the clinical course of hepatocellular carcinoma
Chakraborty et al., 2017, Fibroblast growth factor receptor is a mechanistic link between visceral adiposity and cancer
VanSaun, 2013 Molecular Pathways: Adiponectin and Leptin Signaling in Cancer
Creighton et al., 2012, A gene transcription signature of obesity in breast cancer
Nutrition, Exercise and Cancer Outcomes
Schmitz et al, 2017, Transdisciplinary Research on Energetics and Cancer: From Adipose Tissue to the American Society of Clinical Oncology (ASCO) Summit Recommendations
Koelwyn et al, 2017, Exercise-dependent regulation of the tumour microenvironment
Jones et al, 2016, Exercise and Risk of Cardiovascular Events in Women with Non-metastatic Breast Cancer
Brown et al, 2018, Dose–response effects of exercise on insulin among colon cancer survivors
de Boer et al, 2017, The Mechanisms and Effects of Physical Activity on Breast Cancer
Visceral Adipose Tissue: Its Role in Cancer Progression and Patient Outcomes
Kane et al., 2019, Innate Immune Control of Adipose Tissue Homeostasis
Dickerman et al., 2019, Body fat distribution on computed tomography imaging and prostate cancer risk and mortality in the AGES‐Reykjavik study
Iwase et al., 2016, Impact of body fat distribution on neoadjuvant chemotherapy outcomes in advanced breast cancer patients
Lee et al., 2015, Visceral Adiposity is a Risk Factor for Poor Prognosis in Colorectal Cancer patients Receiving Adjuvant Chemotherapy
Fujiwara et al, 2015, Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma
Guiu et al, 2009, Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer
Moon et al, 2008, Visceral Obesity May Affect Oncologic Outcome in Patients with Colorectal Cancer
Epidemiology of Obesity and Cancer
Iyengar et al., 2018, Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal Body Mass Index A Secondary Analysis of a Randomized Clinical Trial and Observational Study
Gu et al., 2019, Association of serum leptin with breast cancer – A meta-analysis
Calle et al., 2003, Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults
Ligibel et al., 2014, American Society of Clinical Oncology Position Statement on Obesity and Cancer
Goodwin & Chlebowski, 2016, Obesity and Cancer: Insights for Clinicians
Lauby-Secretan et al., 2016, Body Fatness and Cancer — Viewpoint of the IARC Working Group
Fedirko et al., 2014, Pre-diagnostic anthropometry and survival after colorectal cancer diagnosis in Western European populations
Chan et al., 2014, Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies
Niraula et al., 2012, Body size and breast cancer prognosis in relation to hormone receptor and menopausal status: a meta-analysis